Cirrhosis: Clinical sciences

Last updated: January 30, 2025

Cirrhosis: Clinical sciences

PL GastroEnteroLG 2460

PL GastroEnteroLG 2460

Appendicitis: Clinical sciences
Clostridioides difficile infection: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Infectious gastroenteritis: Clinical sciences
Pancreatic cancer: Clinical sciences
Anal cancer: Clinical sciences
Colorectal cancer screening: Clinical sciences
Colorectal cancer: Clinical sciences
Esophageal cancer: Clinical sciences
Gastric cancer: Clinical sciences
Short bowel syndrome: Clinical sciences
Approach to diarrhea (chronic): Clinical sciences
Approach to diarrhea (pediatrics): Clinical sciences
Approach to constipation: Clinical sciences
Esophagitis: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Gastroesophageal varices: Clinical sciences
Mallory-Weiss syndrome: Clinical sciences
Medication-induced constipation: Clinical sciences
Approach to biliary colic: Clinical sciences
Cholecystitis: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Diverticulitis: Clinical sciences
Pilonidal disease: Clinical sciences
Hemorrhoids: Clinical sciences
Anal fissure: Clinical sciences
Fecal impaction: Clinical sciences
Approach to perianal problems: Clinical sciences
Perianal abscess and fistula: Clinical sciences
Acute mesenteric ischemia: Clinical sciences
Chronic mesenteric ischemia: Clinical sciences
Alcohol-induced hepatitis: Clinical sciences
Approach to jaundice (conjugated hyperbilirubinemia): Clinical sciences
Approach to jaundice (unconjugated hyperbilirubinemia): Clinical sciences
Cirrhosis: Clinical sciences
Acute pancreatitis: Clinical sciences
Chronic pancreatitis: Clinical sciences
Approach to ascites: Clinical sciences
Colonic volvulus: Clinical sciences
Ileus: Clinical sciences
Intussusception: Clinical sciences
Ischemic colitis: Clinical sciences
Large bowel obstruction: Clinical sciences
Necrotizing enterocolitis: Clinical sciences
Small bowel obstruction: Clinical sciences
Peptic ulcer disease: Clinical sciences
Stress ulcers: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Intra-abdominal abscess: Clinical sciences
Spontaneous bacterial peritonitis: Clinical sciences
Approach to hepatic masses: Clinical sciences
Approach to pancreatic masses: Clinical sciences
Approach to hematochezia (pediatrics): Clinical sciences
Approach to hematochezia: Clinical sciences
Approach to melena and hematemesis (pediatrics): Clinical sciences
Approach to melena and hematemesis: Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Approach to abdominal wall and groin masses: Clinical sciences
Approach to penetrating neck injury: Clinical sciences
Esophageal perforation: Clinical sciences
Femoral hernias: Clinical sciences
Foreign body aspiration and ingestion (pediatrics): Clinical sciences
Inguinal hernias: Clinical sciences
Umbilical hernias: Clinical sciences
Ventral and incisional hernias: Clinical sciences
Pyloric stenosis: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Cirrhosis refers to chronic progressive fibrotic changes of the liver parenchyma that occur in response to chronic injury and inflammation. A variety of conditions can cause this injury, including viral hepatitis, chronic alcohol use, autoimmune disease, and hereditary conditions like hemochromatosis or alpha-1 antitrypsin deficiency, and the ensuing fibrotic changes eventually impair liver function.

Early in the disease process, cirrhotic patients remain relatively asymptomatic and are considered to have compensated cirrhosis, while those who present with symptoms are considered to have decompensated cirrhosis. Complications due to cirrhosis include spontaneous bacterial peritonitis, ascites, variceal bleeding, hepatic encephalopathy, and hepatorenal syndrome, which can be life-threatening, therefore it’s important to quickly identify these patients who may suddenly decompensate.

Now, if you suspect cirrhosis, first perform an ABCDE assessment to determine if your patient is unstable. Keep in mind that cirrhosis is never unstable unless it's decompensated and the patient develops complications. If this is the case, you may need to secure the airway, breathing, and circulation, which might require intubating the patient, and starting mechanical ventilation. Next, obtain IV access and, if your patient is hypotensive, start IV fluids for volume resuscitation. If there are signs of blood loss, they might even need a transfusion of blood products, such as packed red blood cells, platelets, and even fresh frozen plasma. You should also continuously monitor vital signs.

Additionally, if you suspect decompensated cirrhosis complications, it’s important to identify the underlying cause and complication. To do so, start by performing a focused history and physical examination, and depending on the suspected complication, you may want to order labs or ultrasound.

Alright, if your patient presents with abdominal distension and a palpable fluid wave, and ultrasound reveals free fluid in the peritoneal cavity, that’s ascites. On the other hand, if your patient has fever and abdominal pain, and labs reveal a positive ascitic fluid culture with PMN predominance, your patient has spontaneous bacterial peritonitis. If you notice signs of blood loss, such as melena, hematochezia, and hematemesis, with anemia on labs, think of variceal bleeding.

If instead your patient presents with neurologic signs, such as altered mental status and flapping tremor, also known as asterixis, that’s hepatic encephalopathy. Lastly, if your patient has dark urine and oliguria, and their labs show elevated creatinine, but there’s no evidence of an intrinsic kidney disease, you should think of hepatorenal syndrome, keeping in mind that it’s a diagnosis of exclusion. Once you’ve identified your patient’s specific complication, the management includes treatment of the underlying cause and complication, including consulting the appropriate specialists and the surgical team. For definitive treatment, consider liver transplantation.

Now, here’s a clinical pearl to keep in mind! Active variceal bleeding in a cirrhotic patient carries a high mortality rate and can be challenging to manage. Not only is the presence of variceal bleeding associated with advanced disease in the first place, but variceal bleeding, by its very nature, is under increased pressure from portal hypertension. Further, cirrhotic patients typically have coagulopathy and thrombocytopenia, so their ability to clot is impaired, and gaining control of the bleeding is not easy. Hypotension and hemorrhagic shock may ensue, and volume resuscitation is challenging since albumin is already low. So, you should use colloids, albumin, and blood products to achieve hemodynamic stability. Finally, immediately call the endoscopy team to stop the bleeding.

Ok so let’s go back to the ABCDE assessment where your patient is instead stable and cover compensated cirrhosis. First, obtain a focused history and physical examination, as well as labs, including CBC, CMP, PT, PTT, and possibly ammonia level. In compensated cirrhosis, the remaining healthy liver parenchyma is still able to compensate for systemic demands of liver function. As a result, these patients are usually asymptomatic, and they haven’t developed overt complications from cirrhosis; some may present with varices, but they haven’t had any episodes of variceal bleeding.

Now, since these patients are asymptomatic, they may come to clinical attention on routine lab evaluation. Lab findings might include elevated hepatic transaminases AST and ALT, alkaline phosphatase or ALP, bilirubin, clotting studies like PT and PTT, and ammonia levels; as well as decreased albumin and thrombocytopenia. The combination of these signs, symptoms, and lab findings should lead you to suspect compensated cirrhosis. To confirm the diagnosis, obtain an abdominal ultrasound, as well as ultrasound with elastography. Additionally, you can obtain a liver biopsy, which is the gold standard for diagnosis. Abdominal ultrasound will reveal a small nodular liver, as well as the absence of ascites, while ultrasound with elastography may show increased liver stiffness. Lastly, liver biopsy is not always done, but it may help confirm the diagnosis by showing regenerative nodules and fibrotic tissue.

Okay, now that you’ve confirmed the diagnosis of compensated cirrhosis, let's turn our attention to management. First, you’ll want to treat the underlying cause of cirrhosis. For example, if your patient has viral hepatitis, start them on antiviral medications; or if they use alcohol, encourage abstinence and get them specialty treatment for alcohol use disorder. Also be sure to encourage additional lifestyle modifications, like weight loss for those with steatohepatitis, as well as avoiding heavily processed foods, and limiting hepatotoxic and nephrotoxic medications, like NSAIDs.

Offer vaccination for Hepatitis A and B, and screen for hepatocellular carcinoma every 6 months by obtaining an ultrasound with or without measuring blood concentrations of alpha-fetoprotein. You should also screen for esophageal varices at the time of diagnosis and every 2 to 3 years thereafter. In addition, calculate your patient’s MELD-Na score and Child-Pugh scores. Lastly consult the surgical team for transfer to a transplant center as your patient could be a candidate for liver transplant. Transplant is the only definitive treatment for cirrhosis.

Sources

  1. "AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis" Hepatology (2023)
  2. "AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis" Hepatology (2022)
  3. "Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases" Hepatology (2021)
  4. "Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation" Am Fam Physician (2006)
  5. "Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis" J Coll Physicians Surg Pak (2010)